FIELD: medicine; pediatrics; infectology.
SUBSTANCE: invention can be used to assess the effectiveness of antiviral therapy in infectious mononucleosis in children. In children with acute infectious mononucleosis, 1.5 months after the antiviral treatment, blood serum neopterin is determined by enzyme-linked immunosorbent assay. If the blood serum neopterin level is less than 2.2 nmol/l, the antiviral therapy is considered to be effective. If the neopterin level is more than 2.3 nmol/l, the antiviral therapy is considered to be ineffective.
EFFECT: method provides higher evaluation of the effectiveness of antiviral therapy and improves the clinical course and outcome of the disease by providing the possibility of a more pathogenetically grounded therapeutic approach based on determining the neopterin level in the blood of children by an enzyme-linked immunosorbent assay.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING RELAPSE OF EPSTEIN-BARR VIRAL INFECTION IN CHILDREN | 2023 |
|
RU2820959C1 |
METHOD FOR ASSESSING EFFECTIVENESS OF ANTIVIRAL THERAPY IN INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2023 |
|
RU2823996C1 |
METHOD FOR DETERMINING THERAPEUTIC APPROACH IN CHILDREN WITH ACUTE INFECTIOUS MONONUCLEOSIS | 2023 |
|
RU2821347C1 |
METHOD OF ASSESSING THE SEVERITY OF ACUTE INFECTIOUS MONONUCLEOSIS CAUSED BY THE EPSTEIN-BARR VIRUS IN CHILDREN | 2022 |
|
RU2798079C1 |
METHOD FOR DIAGNOSING THE SEVERITY OF EPSTEIN-BARR VIRUS-INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2022 |
|
RU2797960C1 |
METHOD OF ASSESSING THERAPY EFFECTIVENESS FOR INFECTION CAUSED BY EPSTEIN-BARR VIRUS IN CHILDREN | 2016 |
|
RU2618391C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF CNS ORGANIC LESIONS IN CHILDREN DURING THE ACUTE PERIOD | 2017 |
|
RU2648215C1 |
INSTANT DIAGNOSTIC TECHQNIUE FOR MIXED HERPES VIRAL AND BACTERIAL INFECTIONS IN CHILDREN | 2010 |
|
RU2456616C2 |
METHOD OF FORECASTING SERIOUSNESS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS ETIOLOGY AT CHILDREN | 2008 |
|
RU2360255C1 |
METHOD FOR DIAGNOSING INTRAUTERINE VIRAL INFECTION IN BABIES | 2006 |
|
RU2310851C1 |
Authors
Dates
2024-06-17—Published
2023-06-14—Filed